Sunflower Bank Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$381K Sell
6,028
-3,105
-34% -$215K 0.13% 86
2020
Q2
$703K Buy
9,133
+3,115
+52% +$239K 0.24% 55
2020
Q1
$450K Buy
6,018
+2,400
+66% +$166K 0.17% 75
2019
Q4
$235K Sell
3,618
-6,808
-65% -$443K 0.07% 120
2019
Q3
$661K Sell
10,426
-97
-0.9% -$6.34K 0.21% 75
2019
Q2
$711K Buy
10,523
+65
+0.6% +$4.28K 0.23% 70
2019
Q1
$680K Buy
10,458
+830
+9% +$55.2K 0.2% 74
2018
Q4
$602K Buy
9,628
+275
+3% +$19.2K 0.19% 75
2018
Q3
$722K Sell
9,353
-800
-8% -$60.4K 0.2% 74
2018
Q2
$719K Buy
10,153
+2,605
+35% +$184K 0.21% 76
2018
Q1
$569K Buy
7,548
+1,280
+20% +$102K 0.16% 84
2017
Q4
$449K Sell
6,268
-3,885
-38% -$295K 0.12% 95
2017
Q3
$823K Buy
+10,153
New +$776K 0.3% 45

Other funds holding GILD

Sunflower Bank Wealth Management's GILD Position: Q3 2020 in Review

Sunflower Bank Wealth Management reduced its Gilead Sciences (GILD) stake by 34% in Q3 2020, selling an estimated $215K and leaving 6,028 shares worth $381K. The position accounts for 0.13% of the portfolio, ranked #86.

Sunflower Bank Wealth Management first reported a position in GILD in Q3 2017 and has held it in 13 quarters since. The position peaked at $823K in Q3 2017. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Sunflower Bank Wealth Management held 6,028 shares of Gilead Sciences worth $381K as of Q3 2020.
  • Sunflower Bank Wealth Management sold 3,105 Gilead Sciences shares in Q3 2020, an estimated $215K.
  • Gilead Sciences made up 0.13% of Sunflower Bank Wealth Management's portfolio in Q3 2020, its #86 holding.
  • Sunflower Bank Wealth Management first reported a position in Gilead Sciences in Q3 2017 and has held it in 13 quarters since.
  • Sunflower Bank Wealth Management's Gilead Sciences position peaked at $823K in Q3 2017.
  • 1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Sunflower Bank Wealth Management's 13F filing for Q3 2020, filed 23 Oct 2020.